Buy Zarontin 250 mg/5mL Ethosuximide

Zarontin 250 mg/5mL is an oral solution used to manage certain types of seizures. This ethosuximide-based medication is designed for effective seizure control and is available in a convenient liquid form.

Strength

250 mg/5mL

Pack Size

1 BOTTLE, PLASTIC in 1 CARTON (0071-2418-19) / 474 mL in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

Parke-Davis Div of Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Zarontin 250 mg/5mL is primarily used for the treatment of absence seizures, a type of epileptic seizure. Ethosuximide, the active ingredient, works by stabilizing electrical activity in the brain. This medication is often prescribed to control and prevent seizures in individuals diagnosed with absence epilepsy. Understanding what is Zarontin used for can help patients manage their condition more effectively.

Side Effects

Common effects of Zarontin 250 mg/5mL may include drowsiness, dizziness, and stomach upset. Some users might experience nausea or vomiting. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Zarontin 250 mg/5mL should be handled with care. It is important to follow the prescribed dosage and administration instructions. Patients should avoid activities that require alertness until they know how the medication affects them. Regular monitoring and follow-up with a healthcare provider are recommended.

Avoid Interactions

Zarontin 250 mg/5mL may interact with other medications, including those that affect liver enzymes. Alcohol and certain over-the-counter drugs can also influence its effectiveness. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Zarontin is used to manage absence seizures, a type of epileptic seizure, by stabilizing electrical activity in the brain.

Zarontin 250 mg/5mL is an oral solution that should be taken as directed by a healthcare provider, typically with or without food.

Common side effects may include drowsiness, dizziness, stomach upset, nausea, and vomiting.

Zarontin may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Long-term use of Zarontin should be monitored by a healthcare provider to ensure its continued safety and effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.